Many synthetic peptides have been developed for diagnosis and therapy of human cancers
based on their ability to target specific receptors on cancer cell surface or to penetrate the …

Non-invasive investigation of integrin expression is an interesting approach in nuclear
medicine department. Indeed, integrins are overexpressed in a wide array of diseases …

The neurotensin receptors are overexpressed in various tumor types, especially in highly
progressive pancreatic tumors. As this cancer has a poor 5‐year survival prognosis, there is …

The neurotensin (NT) receptor-1 (NTS1) is overexpressed in a variety of carcinomas and is
therefore an interesting target for imaging with positron emission tomography (PET). The aim …

The purpose of this study is to develop peptide-based platelet-derived growth factor receptor
β (PDGFR β) imaging probes and examine the effects of several linkers, namely un-natural …

Targeting the prostate-specific membrane antigen (PSMA) with radiopharmaceuticals for
imaging and/or therapy has demonstrated significant advancement in the management of …

Simple Summary Cancer diagnostics based on molecular imaging techniques such as
positron emission tomography (PET) requires radiolabeled tracers, which are taken up by …

Background: Radiolabeled peptides, designed to bind with high affinity receptors selectively
expressed on cell membranes of different human tissues, represent valuable tools for in vivo …

Recent years have seen considerable progress in understanding the biochemistry of cancer.
For example, more significance is now assigned to the tumor microenvironment, especially …

Due to its expression in various malignant tumors, the neurotensin receptor 1 (NTS1R) has
been suggested and explored as a target for tumor diagnosis and therapy. Animal model …